464 related articles for article (PubMed ID: 1324153)
1. Effects of vasoactive intestinal peptide on adenosine 3',5'-monophosphate, ornithine decarboxylase, and cell growth in a human colon cell line.
Yu D; Seitz PK; Selvanayagam P; Rajaraman S; Townsend CM; Cooper CW
Endocrinology; 1992 Sep; 131(3):1188-94. PubMed ID: 1324153
[TBL] [Abstract][Full Text] [Related]
2. Effects of parathyroid hormone-related peptide on adenosine 3',5'-monophosphate and ornithine decarboxylase in a human colonic cell line.
Yu D; Seitz PK; Selvanayagam P; Rajaraman S; Townsend CM; Cooper CW
Endocrinology; 1992 Apr; 130(4):1993-2000. PubMed ID: 1312434
[TBL] [Abstract][Full Text] [Related]
3. Involvement of ornithine decarboxylase in the control of proliferation of the HT29 human colon cancer cell line. Effect of vasoactive intestinal peptide on enzyme activity.
Gamet L; Cazenave Y; Trocheris V; Denis-Pouxviel C; Murat JC
Int J Cancer; 1991 Feb; 47(4):633-8. PubMed ID: 1847359
[TBL] [Abstract][Full Text] [Related]
4. Vasoactive intestinal peptide (VIP) stimulates in vitro growth of VIP-1 receptor-bearing human pancreatic adenocarcinoma-derived cells.
Jiang S; Kopras E; McMichael M; Bell RH; Ulrich CD
Cancer Res; 1997 Apr; 57(8):1475-80. PubMed ID: 9108448
[TBL] [Abstract][Full Text] [Related]
5. Vasoactive intestinal peptide and intraocular pressure: adenylate cyclase activation and binding sites for vasoactive intestinal peptide in membranes of ocular ciliary processes.
Mittag TW; Tormay A; Podos SM
J Pharmacol Exp Ther; 1987 Apr; 241(1):230-5. PubMed ID: 3033201
[TBL] [Abstract][Full Text] [Related]
6. Cyclic AMP-dependent protein kinase in Molt 4b lymphoblasts: identification by photoaffinity labeling and activation in intact cells by vasoactive intestinal polypeptide (VIP) and peptide histidine isoleucine (PHI).
O'Dorisio MS; Wood CL; Wenger GD; Vassalo LM
J Immunol; 1985 Jun; 134(6):4078-86. PubMed ID: 2985703
[TBL] [Abstract][Full Text] [Related]
7. Effect of vasoactive intestinal peptide on gastric adenocarcinoma.
Li GH; Qian W; Song GQ; Hou XH
J Gastroenterol Hepatol; 2007 Aug; 22(8):1328-35. PubMed ID: 17559364
[TBL] [Abstract][Full Text] [Related]
8. Vasoactive intestinal polypeptide inhibits c-myc expression and growth of human gastric carcinoma cells.
Kim SW; Beauchamp RD; Townsend CM; Thompson JC
Surgery; 1991 Aug; 110(2):270-5; discussion 276. PubMed ID: 1713357
[TBL] [Abstract][Full Text] [Related]
9. A human melanoma-derived cell line (IGR39) with a very high number of vasoactive-intestinal-peptide (VIP) receptors. 2. Effect of VIP on cAMP production and on cell-surface VIP-binding sites.
Martin JM; Luis J; Marvaldi J; Pichon J; Pic P
Eur J Biochem; 1989 Mar; 180(2):435-9. PubMed ID: 2538331
[TBL] [Abstract][Full Text] [Related]
10. Breast cancer growth is inhibited by vasoactive intestinal peptide (VIP) hybrid, a synthetic VIP receptor antagonist.
Zia H; Hida T; Jakowlew S; Birrer M; Gozes Y; Reubi JC; Fridkin M; Gozes I; Moody TW
Cancer Res; 1996 Aug; 56(15):3486-9. PubMed ID: 8758916
[TBL] [Abstract][Full Text] [Related]
11. Somatostatin inhibits basal and vasoactive intestinal peptide-stimulated hormone release by different mechanisms in GH pituitary cells.
Dorflinger LJ; Schonbrunn A
Endocrinology; 1983 Nov; 113(5):1551-8. PubMed ID: 6138245
[TBL] [Abstract][Full Text] [Related]
12. Functional VIP receptors in the human mucus-secreting colonic epithelial cell line CL.16E.
Laburthe M; Augeron C; Rouyer-Fessard C; Roumagnac I; Maoret JJ; Grasset E; Laboisse C
Am J Physiol; 1989 Mar; 256(3 Pt 1):G443-50. PubMed ID: 2538074
[TBL] [Abstract][Full Text] [Related]
13. Effects of parathyroid hormone on ornithine decarboxylase activity in human osteosarcoma cells.
Goto H; Matsui-Yuasa I; Otani S; Morisawa S; Nishizawa Y; Morii H
Arch Biochem Biophys; 1991 May; 286(2):316-22. PubMed ID: 1654784
[TBL] [Abstract][Full Text] [Related]
14. Characterization of vasoactive intestinal peptide receptors in human colonic epithelial cells.
Broyart JP; Dupont C; Laburthe M; Rosselin G
J Clin Endocrinol Metab; 1981 Apr; 52(4):715-21. PubMed ID: 6259191
[TBL] [Abstract][Full Text] [Related]
15. Relationship of ornithine decarboxylase activity and cAMP metabolism to proliferation of normal human bronchial epithelial cells.
Willey JC; Laveck MA; McClendon IA; Lechner JF
J Cell Physiol; 1985 Aug; 124(2):207-12. PubMed ID: 2995414
[TBL] [Abstract][Full Text] [Related]
16. Ontogenic development of vasoactive intestinal peptide receptors in rat intestinal cells and liver.
Chastre E; Emami S; Rosselin G; Gespach C
Endocrinology; 1987 Dec; 121(6):2211-21. PubMed ID: 2824182
[TBL] [Abstract][Full Text] [Related]
17. Multiple pathways for the regulation of ornithine decarboxylase in intestinal epithelial cells.
Ginty DD; Marlowe M; Pekala PH; Seidel ER
Am J Physiol; 1990 Mar; 258(3 Pt 1):G454-60. PubMed ID: 2107756
[TBL] [Abstract][Full Text] [Related]
18. Vasoactive intestinal peptide receptor regulation and reversible desensitization in human colonic carcinoma cells in culture.
Boissard C; Marie JC; Hejblum G; Gespach C; Rosselin G
Cancer Res; 1986 Sep; 46(9):4406-13. PubMed ID: 3015387
[TBL] [Abstract][Full Text] [Related]
19. Parathyroid hormone-induced ornithine decarboxylase activity in fetal rat osteoblasts.
Van Leeuwen JP; Bos MP; Herrmann-Erlee MP
J Bone Miner Res; 1989 Aug; 4(4):485-92. PubMed ID: 2554685
[TBL] [Abstract][Full Text] [Related]
20. Vasoactive intestinal peptide and forskolin regulate proliferation of the HT29 human colon adenocarcinoma cell line.
Gamet L; Murat JC; Remaury A; Remesy C; Valet P; Paris H; Denis-Pouxviel C
J Cell Physiol; 1992 Mar; 150(3):501-9. PubMed ID: 1371513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
